TRIAL_ID,LSO,DBL,CLOSE_OUT,LSO_INTERIM_2,LSO_INTERIM_3,LSO_INTERIM_4,DBL_INTERIM_2,DBL_INTERIM_3,DBL_INTERIM_4,THERAPEUTIC_AREA,STUDY_PHASE,STUDY_STATUS,PLANNED_ENROLLMENT,CRO,COUNTRY
10201806004,2/26/2021,4/23/2021,56,0,0,0,0,0,0,Oncology,II,Enrollment Complete,32,Takeda PRA Development Center, Japan
10201806038,9/28/2019,1/9/2020,103,0,0,0,0,0,0,GI,I,Closed,96,Takeda PRA Development Center, Japan
10201806040,2/27/2018,8/16/2018,170,0,0,0,0,0,0,GI,III,Closed,278,MEDISCIENCE PLANNING INC, Japan
0624-209,6/23/2017,7/27/2017,34,0,0,0,0,0,0,Plasma Derived Therapy,III,Completed,8,Parexel, Japan
10201806043,9/20/2020,12/18/2020,89,0,0,0,0,0,0,Oncology,II,"Active, Not Recruiting",16,MEDISCIENCE PLANNING INC, Japan
10201806007,4/13/2018,6/18/2018,66,0,0,0,0,0,0,CNS,I,Closed,56,MEDISCIENCE PLANNING INC, Japan
10201902001,4/1/2018,4/1/2018,0,0,0,0,0,0,0,Oncology,I,Enrolling,14,PPD, Japan
10201806013,8/4/2019,11/1/2019,89,0,0,0,0,0,0,Oncology,II,Closed,30,EPS, Japan
10201806041,7/4/2019,8/9/2019,36,0,0,0,0,0,0,GI,III,Closed,110,MEDISCIENCE PLANNING INC, Japan
10201806002,8/25/2020,11/19/2020,86,0,0,0,0,0,0,Oncology,II,Enrollment Complete,35,MEDISCIENCE PLANNING INC, Japan
10201806044,3/31/2021,5/14/2021,44,0,0,0,0,0,0,Oncology,II,Enrollment Complete,15,MEDISCIENCE PLANNING INC, Japan
1-17X9HR,2/25/2021,3/24/2021,27,0,0,0,0,0,0,GI,III,Execution,302,IQVIA, China
71102,3/24/2021,3/24/2021,0,0,0,0,0,0,0,RGH,III,Execution,24,IQVIA," Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Italy, Netherlands (the), Norway, Poland, Russian Federation (the), Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
71301,9/9/2020,10/22/2020,43,0,0,0,0,0,0,RGH,III,Completed,22,IQVIA," Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Italy, Netherlands (the), Norway, Russian Federation (the), Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-106C5U,11/1/2016,12/19/2016,48,0,0,0,0,0,0,CNS,II,Cancelled,36,IQVIA," Czechia, Estonia, Latvia, Russian Federation (the), Spain, United Kingdom of Great Britain and Northern Ireland (the)"
10201806042,3/11/2018,4/6/2018,26,0,0,0,0,0,0,CVM,I,Closed,23,MEDISCIENCE PLANNING INC, Japan
1-10E05V,1/21/2014,3/13/2014,51,0,0,0,0,0,0,NULL,II,Closed,104,Quintiles," Belgium, Brazil, Hungary, Italy, Mexico, Poland, Portugal, United States of America (the)"
1-1CJZCS,11/9/2016,1/11/2017,63,0,0,0,0,0,0,CNS,I,Closed,9,PPD, United States of America (the)
10201810002,11/17/2020,12/15/2020,28,0,0,0,0,0,0,GI,I,Planned,24,Takeda PRA Development Center, Japan
10201806015,9/30/2020,10/28/2020,28,0,0,0,0,0,0,Oncology,I,Closed,9,Takeda PRA Development Center, Japan
10201807001,10/27/2019,11/22/2019,26,0,0,0,0,0,0,CNS,I,Closed,54,Takeda PRA Development Center, Japan
91501,3/30/2021,5/11/2021,42,0,0,0,0,0,0,RGH,IIIb,Execution,24,IQVIA," Algeria, Croatia, India, Malaysia, North Macedonia, Poland, Romania, Serbia, South Africa, Thailand, Turkey, Ukraine"
1-1FQOMT,8/24/2017,10/19/2017,56,0,0,0,0,0,0,CNS,I,Closed,12,Quintiles, United Kingdom of Great Britain and Northern Ireland (the)
10201806014,3/31/2019,5/29/2019,59,0,0,0,0,0,0,Oncology,I,In Follow-Up,14,Takeda PRA Development Center, Japan
1-10ELRQ,11/12/2020,12/12/2020,30,0,0,0,0,0,0,Oncology,I,Cancelled,25,NULL,NULL
1-10ELOL,3/13/2020,5/13/2020,61,0,0,0,0,0,0,Oncology,I,Closed,80,PPD, Japan
10201901001,12/18/2019,2/20/2020,64,0,0,0,0,0,0,Others,I,Closed,10,PRA, Japan
10201806026,10/30/2018,1/24/2019,86,0,0,0,0,0,0,GI,I,Closed,552,MEDISCIENCE PLANNING INC, Japan
1-10FGWP,3/26/2021,4/25/2021,30,0,0,0,0,0,0,Oncology,III,Cancelled,300,NULL,NULL
10201806025,2/26/2018,5/29/2018,92,0,0,0,0,0,0,GI,III,Closed,484,EPS, Japan
1-10ELRF,11/12/2020,12/12/2020,30,0,0,0,0,0,0,Oncology,I,Cancelled,25,NULL,NULL
1-10ELUG,2/4/2020,5/4/2020,90,0,0,0,0,0,0,Oncology,II,Cancelled,150,NULL,NULL
1-1FQOV2,2/8/2018,3/30/2018,50,0,0,0,0,0,0,GI,I,Closed,40,Hangzhou Tigermed Consulting, China
1-10FGZM,3/22/2021,5/13/2021,52,0,0,0,0,0,0,Oncology,I,Cancelled,6,PRA, Netherlands (the)
1-1FQOVK,6/14/2018,8/14/2018,61,0,0,0,0,0,0,GI,III,Closed,200,Hangzhou Tigermed Consulting,NULL
1-1274SY,4/14/2021,5/14/2021,30,0,0,0,0,0,0,Oncology,I,Cancelled,6,NULL,NULL
1-10FH45,4/30/2020,8/1/2020,93,0,0,0,0,0,0,Oncology,I,Cancelled,12,NULL,NULL
1-22IBXF,12/30/2020,1/27/2021,28,0,0,0,0,0,0,Oncology,I,In Close Out,20,PRA, United States of America (the)
1-12755U,6/13/2021,6/14/2021,1,0,0,0,0,0,0,Oncology,I/II,Execution,125,PPD," Canada, China, France, Germany, Italy, Japan, Spain, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
10201806027,8/13/2019,9/30/2019,48,0,0,0,0,0,0,CVM,III,Closed,30,MEDISCIENCE PLANNING INC, Japan
1-10FL6M,5/28/2020,6/27/2020,30,0,0,0,0,0,0,Oncology,II,Cancelled,150,NULL,NULL
1-127596,12/3/2017,12/31/2017,28,0,0,0,0,0,0,Oncology,III,Planned,400,PPD,NULL
1-106BXY,4/5/2016,5/2/2016,27,0,0,0,0,0,0,CNS,I,Closed,10,Quintiles," Bulgaria, Netherlands (the), Spain"
1-10XM9M,11/19/2018,1/17/2019,59,0,0,0,0,0,0,GI,IV,Closed,300,Hangzhou Tigermed Consulting, China
1-12LDAB,7/14/2017,8/16/2017,33,0,0,0,0,0,0,GI,I,Closed,104,PRA, United States of America (the)
1-23H333,1/21/2021,2/18/2021,28,0,0,0,0,0,0,GI,I,Planned,24,Celerion,NULL
1-10ELPN,12/30/2020,1/29/2021,30,0,0,0,0,0,0,Oncology,I,Closed,44,PRA, Netherlands (the)
1-10ELXD,2/11/2020,3/17/2020,35,0,0,0,0,0,0,Oncology,II,Enrollment Complete,60,PRA," Czechia, France, Greece, Netherlands (the), Poland, United States of America (the)"
1-10FH04,2/23/2021,3/25/2021,30,0,0,0,0,0,0,Oncology,I,Cancelled,25,NULL,NULL
1-18NLQH,12/10/2018,2/11/2019,63,0,0,0,0,0,0,CNS,I,Terminated,186,PPD, United States of America (the)
1-1DC20E,5/3/2020,6/22/2020,50,0,0,0,0,0,0,CNS,I,Cancelled,16,Celerion, United States of America (the)
1-1EIATT,1/23/2017,3/21/2017,57,0,0,0,0,0,0,GI,III,Closed,204,Quintiles, Russian Federation (the)
1-1EIAU4,2/17/2017,4/21/2017,63,0,0,0,0,0,0,GI,III,Closed,150,Quintiles, Korea (the Republic of)
1-1146BQ,7/6/2018,8/17/2018,42,0,0,0,0,0,0,GI,II,Closed,214,Quintiles," Belgium, Bulgaria, Czechia, Estonia, Poland, United Kingdom of Great Britain and Northern Ireland (the)"
1-23H33O,1/26/2021,2/23/2021,28,0,0,0,0,0,0,GI,I,Planned,24,Celerion,NULL
1-17J3FB,10/13/2020,11/17/2020,35,0,0,0,0,0,0,CNS,IIA,Cancelled,90,PRA,NULL
1-17VBPS,11/2/2018,12/28/2018,56,0,0,0,0,0,0,Oncology,IB,Closed,24,PRA, United States of America (the)
1-1FQORN,3/3/2020,4/7/2020,35,0,0,0,0,0,0,CNS,I,Cancelled,6,NULL, United States of America (the)
1-1LEUIX,1/2/2020,2/13/2020,42,0,0,0,0,0,0,CNS,III,Cancelled,500,PRA,NULL
1-1FQOS7,10/20/2019,11/22/2019,33,0,0,0,0,0,0,CNS,I,Cancelled,24,NULL, United States of America (the)
1-1BP8VZ,5/11/2017,5/17/2017,6,0,0,0,0,0,0,GI,I,Closed,30,Quintiles, Korea (the Republic of)
1-23H34G,2/19/2021,3/30/2021,39,0,0,0,0,0,0,GI,I,Completed,6,Celerion,NULL
1-10FLEN,5/4/2021,6/15/2021,42,0,0,0,0,0,0,Oncology,I,Execution,42,PPD," Spain, United States of America (the)"
1-13NNMT,12/28/2020,1/27/2021,30,0,0,0,0,0,0,Oncology,I,Terminated,1,PRA, Hungary
1-23H35R,5/18/2021,6/22/2021,35,0,0,0,0,0,0,GI,I,Planned,24,Celerion, United States of America (the)
1-1W19RW,9/15/2019,12/9/2019,85,0,0,0,0,0,0,GI,IIb,Cancelled,200,PRA," Australia, Canada, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-1MYTTL,4/16/2020,6/16/2020,61,0,0,0,0,0,0,NULL,I,Planned,48,NULL,NULL
1-1Y6NEZ,12/28/2020,5/25/2021,148,0,0,0,0,0,0,GI,I/II,In Close Out,80,TFS," Belgium, France, Lithuania, Spain"
1-19NQKS,1/1/2021,2/5/2021,35,0,0,0,0,0,0,CNS,II,Cancelled,240,PRA," Japan, United States of America (the)"
1-24REM6,2/1/2020,2/25/2020,24,0,0,0,0,0,0,Oncology,II,Cancelled,150,NULL,NULL
1-1DUG15,2/16/2021,4/13/2021,56,0,0,0,0,0,0,Oncology,III,Enrolling,558,PRA," Argentina, Australia, Austria, Belgium, Brazil, Canada, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea (the Republic of), Norway, Poland, Portugal, Romania, Russian Federation (the), Singapore, Spain, Sweden, Switzerland, Taiwan (Province of China), United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-24REKY,2/27/2020,7/31/2020,155,0,0,0,0,0,0,NULL,I/II,Closed,137,PRA," Spain, United States of America (the)"
1-1H5VVF,12/18/2018,1/22/2019,35,0,0,0,0,0,0,CNS,I,Cancelled,1,PRA, United States of America (the)
1-24REMA,12/4/2016,6/26/2017,204,0,0,0,0,0,0,NULL,I,Closed,1,INC Research, United States of America (the)
1-24RENV,9/29/2020,11/18/2020,50,0,0,0,0,0,0,Oncology,II,Planned,80,NULL,NULL
1-26JYIY,10/4/2018,11/1/2018,28,0,0,0,0,0,0,GI,I,Closed,102,Celerion, United States of America (the)
1-1KXHY2,5/13/2017,6/26/2017,44,0,0,0,0,0,0,GI,I,Closed,52,PRA, United States of America (the)
10201806030,10/7/2017,12/15/2017,69,0,0,0,0,0,0,GI,I,Closed,24,MEDISCIENCE PLANNING INC, Japan
1-1S6QUZ,12/10/2019,2/24/2020,76,0,0,0,0,0,0,CNS,II,Closed,23,PRA, United Kingdom of Great Britain and Northern Ireland (the)
1-1TM8YR,6/25/2020,8/20/2020,56,0,0,0,0,0,0,GI,I,Enrollment Complete,190,Celerion, United States of America (the)
1-1ZTG51,3/11/2018,7/19/2018,130,0,0,0,0,0,0,GI,IIA,Closed,48,PRA, United States of America (the)
1-26UPFL,8/30/2018,10/30/2018,61,0,0,0,0,0,0,Oncology,II,In Close Out,40,CMIC,NULL
1-25CUQB,2/2/2021,3/2/2021,28,0,0,0,0,0,0,GI,I,Planned,138,NULL,NULL
1-274PTK,11/9/2019,12/9/2019,30,0,0,0,0,0,0,Oncology,I,Completed,6,Celerion, United States of America (the)
1-25CUUR,9/9/2018,10/3/2018,24,0,0,0,0,0,0,CNS,I,Closed,48,PRA, United States of America (the)
1-1VZYNQ ,7/24/2017,8/28/2017,35,0,0,0,0,0,0,GI,I,Closed,11,PRA, United States of America (the)
1-21HO75,7/11/2017,8/18/2017,38,0,0,0,0,0,0,GI,I,Closed,12,PRA, United States of America (the)
1-26JYJ8,6/19/2021,6/22/2021,3,0,0,0,0,0,0,Oncology,I,Start Up,20,PRA," France, Italy, Netherlands (the), Spain"
1-1ASDLD,1/5/2019,3/1/2019,55,0,0,0,0,0,0,CNS,I,Cancelled,46,PPD, United States of America (the)
1-2DAR45,10/6/2019,11/8/2019,33,0,0,0,0,0,0,CNS,I,Cancelled,36,PRA, United Kingdom of Great Britain and Northern Ireland (the)
1-1VZYOT,9/11/2018,10/15/2018,34,0,0,0,0,0,0,GI,I,Closed,24,PRA," Czechia, Slovakia"
1-2H7217,4/12/2021,6/12/2021,61,0,0,0,0,0,0,Oncology,III,Enrolling,246,PRA," Argentina, Austria, Canada, Chile, China, Croatia, France, Germany, Greece, Hong Kong, Italy, Korea (the Republic of), Mexico, Romania, Russian Federation (the), Spain, Sweden, Taiwan (Province of China), Thailand, United States of America (the)"
1-2UGK0D,11/6/2018,11/27/2018,21,0,0,0,0,0,0,CNS,0,Closed,12,NULL, United States of America (the)
1-2PJ2DG,2/27/2021,4/25/2021,57,0,0,0,0,0,0,Oncology,II,Planned,1,NULL,NULL
1-1DC1ZJ,5/16/2018,6/7/2018,22,0,0,0,0,0,0,CNS,I,Closed,40,PRA, United States of America (the)
1-2GG2AA,11/7/2018,12/11/2018,34,0,0,0,0,0,0,CNS,IB,Closed,20,PRA, United States of America (the)
1-23H347,3/15/2021,5/11/2021,57,0,0,0,0,0,0,GI,I,Closed,12,Celerion, United States of America (the)
1-1DUG1R,3/31/2021,5/26/2021,56,0,0,0,0,0,0,Oncology,III,Planned,460,PRA,NULL
1-23H35C,4/22/2021,5/20/2021,28,0,0,0,0,0,0,GI,I,Cancelled,24,Celerion,NULL
1-2V644J,4/27/2021,6/22/2021,56,0,0,0,0,0,0,GI,IIB,Cancelled,60,NULL,NULL
1-1FFWFN,12/4/2020,1/29/2021,56,0,0,0,0,0,0,NULL,III,Planned,288,TBD,NULL
1-24RE13,7/12/2019,8/27/2019,46,0,0,0,0,0,0,GI,IIA,Closed,48,PRA, United States of America (the)
1-24RELR,2/29/2020,6/5/2020,97,0,0,0,0,0,0,Oncology,II,Closed,222,PRA," Australia, Austria, Belgium, Canada, Denmark, France, Germany, Hong Kong, Italy, Korea (the Republic of), Netherlands (the), Norway, Singapore, Spain, Sweden, Switzerland, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-30EDQR,9/24/2020,10/22/2020,28,0,0,0,0,0,0,CNS,II,Cancelled,30,PRA,NULL
1-2TFQBD,12/28/2020,2/22/2021,56,0,0,0,0,0,0,CNS,0,Cancelled,60,TBD,NULL
1-24REMU,11/3/2016,6/26/2017,235,0,0,0,0,0,0,NULL,I,Closed,1,INC Research, United States of America (the)
1-2IFHK7,11/27/2018,12/11/2018,14,0,0,0,0,0,0,GI,I,Closed,204,Celerion, United States of America (the)
1-2LTMNJ,11/17/2020,1/12/2021,56,0,0,0,0,0,0,CNS,I,Planned,32,Celerion, United States of America (the)
1-2UGJLX,5/18/2020,6/17/2020,30,0,0,0,0,0,0,NULL,I,Cancelled,20,NULL,NULL
1-30EE6J,7/11/2019,8/15/2019,35,0,0,0,0,0,0,CNS,I,Closed,24,PRA," Netherlands (the), United States of America (the)"
1-2UGJGD,5/19/2021,6/16/2021,28,0,0,0,0,0,0,GI,IIB,Enrolling,180,PRA," Belgium, Germany, United States of America (the)"
1-2UGJKJ,4/30/2021,6/4/2021,35,0,0,0,0,0,0,CNS,I,On Hold,40,PRA,NULL
1-24RENC,9/3/2019,11/12/2019,70,0,0,0,0,0,0,Oncology,II,In Close Out,80,NULL, Japan
1-2X77JU,7/30/2019,10/17/2019,79,0,0,0,0,0,0,CNS,0,Closed,44,PRA, United States of America (the)
1-25CUNJ,10/30/2020,12/25/2020,56,0,0,0,0,0,0,NULL,II,Planned,250,TBD,NULL
1-32PVRW,12/30/2020,1/22/2021,23,0,0,0,0,0,0,GI,I,Planned,160,Celerion, United States of America (the)
1-25CUNT,5/20/2021,6/14/2021,25,0,0,0,0,0,0,GI,IIB,Enrolling,205,PRA," Belgium, Italy, Japan, Poland, United States of America (the)"
1-2J1GSP,2/1/2019,5/22/2019,110,0,0,0,0,0,0,Oncology,I,Closed,68,PRA, United States of America (the)
1-34WP2Q,5/12/2019,6/14/2019,33,0,0,0,0,0,0,GI,I,Closed,6,Celerion, United States of America (the)
1-32PVS7,6/29/2020,8/12/2020,44,0,0,0,0,0,0,CNS,I,Completed,160,PRA, United States of America (the)
1-34WP30 ,3/18/2019,4/15/2019,28,0,0,0,0,0,0,GI,I,Closed,120,Celerion,NULL
10201806033,9/26/2018,11/22/2018,57,0,0,0,0,0,0,CNS,I,Closed,101,MEDISCIENCE PLANNING INC, Japan
1-39F7HP,2/23/2021,3/30/2021,35,0,0,0,0,0,0,CNS,II,Planned,72,INC Research,NULL
1-359QPS,8/25/2020,10/20/2020,56,0,0,0,0,0,0,NULL,I,Cancelled,81,NULL,NULL
1-2TFPVR,11/6/2020,2/26/2021,112,0,0,0,0,0,0,GI,I,Enrolling,122,NULL, United States of America (the)
1-39REHV,12/3/2019,1/24/2020,52,0,0,0,0,0,0,CNS,I,Closed,16,Celerion, United States of America (the)
1-359QOT,10/28/2020,2/16/2021,111,0,0,0,0,0,0,Oncology,II,Enrollment Complete,24,PRA, United Kingdom of Great Britain and Northern Ireland (the)
1-36QQKT,4/28/2021,6/23/2021,56,0,0,0,0,0,0,CNS,II,Cancelled,100,NULL,NULL
1-1FFWFY,12/4/2020,1/29/2021,56,0,0,0,0,0,0,NULL,III,Planned,288,NULL,NULL
1-3CYXR9,4/9/2016,6/3/2016,55,0,0,0,0,0,0,CNS,I,Planned,40,NULL,NULL
1-1FFWG7,4/10/2021,6/4/2021,55,0,0,0,0,0,0,NULL,III,Planned,600,NULL,NULL
1-3CYXSK,6/24/2016,10/9/2017,472,0,0,0,0,0,0,CNS,I,Planned,24,TBD,NULL
1-3CYXY6,8/27/2019,10/16/2019,50,0,0,0,0,0,0,CNS,I,Planned,70,NULL,NULL
1-37HZ3U,3/4/2021,4/1/2021,28,0,0,0,0,0,0,CNS,II,Cancelled,90,IQVIA, China
1-1FQOKZ,3/23/2021,5/18/2021,56,0,0,0,0,0,0,CNS,II,Cancelled,15,NULL,NULL
1-3D8NXB,3/3/2021,6/14/2021,103,0,0,0,0,0,0,GI,I,Completed,42,Precision for Medicine, United States of America (the)
1-39REQR,1/11/2021,2/9/2021,29,0,0,0,0,0,0,CNS,I,Cancelled,152,PRA,NULL
1-2U8J3J,9/27/2020,10/30/2020,33,0,0,0,0,0,0,CNS,II,Cancelled,70,PRA, China
1-1FQOSG,5/1/2020,6/5/2020,35,0,0,0,0,0,0,CNS,I,Cancelled,24,NULL, United States of America (the)
1-39F7S9,11/5/2020,12/10/2020,35,0,0,0,0,0,0,CNS,II,Planned,48,NULL,NULL
1-3DYC4P,2/27/2021,4/23/2021,55,0,0,0,0,0,0,CNS,I,Planned,16,NULL,NULL
1-3CYXUN,9/21/2016,10/26/2016,35,0,0,0,0,0,0,CNS,I,Cancelled,12,TBD,NULL
1-3CYXTV,9/21/2016,10/26/2016,35,0,0,0,0,0,0,CNS,I,Cancelled,24,TBD,NULL
1-3ELU52,4/8/2021,5/27/2021,49,0,0,0,0,0,0,CNS,I,Planned,24,NULL,NULL
1-3DYCO1,4/12/2021,5/10/2021,28,0,0,0,0,0,0,GI,I,Cancelled,24,NULL,NULL
1-3LQ411,11/17/2020,3/18/2021,121,0,0,0,0,0,0,CNS,I,Closed,32,PRA,NULL
1-3ELU49,4/14/2020,6/10/2020,57,0,0,0,0,0,0,CNS,I,Closed,16,Celerion, United States of America (the)
1-3S3AWP,11/27/2020,2/19/2021,84,1,0,0,0,0,0,NULL,IB,Planned,40,PPD,NULL
161504,1/15/2021,6/1/2021,137,0,0,0,0,0,0,Plasma Derived Therapy,IV,Execution,40,IQVIA," Czechia, Denmark, France, Greece, Hungary, Slovakia, Sweden, United Kingdom of Great Britain and Northern Ireland (the)"
1-8VEAE,8/25/2013,10/28/2013,64,0,0,0,0,0,0,NULL,I,Closed,72,PPD, United States of America (the)
1-3DYCDB,4/23/2021,5/21/2021,28,0,0,0,0,0,0,GI,0,Enrolling,100,Cambridge Cognition, United States of America (the)
1-8VEAZ,5/22/2012,8/17/2012,87,0,0,0,0,0,0,NULL,I,Closed,66,PPD, United States of America (the)
1-3TL6IT,4/22/2021,5/20/2021,28,0,0,0,0,0,0,GI,I,Planned,40,NULL,NULL
1-1H5VVZ,11/13/2019,1/8/2020,56,0,0,0,0,0,0,NULL,I,Cancelled,12,NULL,NULL
1-3DYC4Y,5/31/2021,6/21/2021,21,0,0,0,0,0,0,CNS,I,Execution,54,Celerion,NULL
1-1J88EV ,6/7/2021,6/23/2021,16,0,0,0,0,0,0,CNS,II,Cancelled,240,NULL,NULL
1-3DYCNO,12/18/2020,1/15/2021,28,0,0,0,0,0,0,GI,I,Cancelled,100,TBD,NULL
1-1M2SHV,6/26/2020,9/8/2020,74,0,0,0,0,0,0,Oncology,II/III,Enrollment Complete,120,PPD," Australia, Belgium, Canada, Czechia, Denmark, France, Germany, Greece, Israel, Italy, Japan, Netherlands (the), Norway, Russian Federation (the), Spain, Sweden, Turkey, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-8UNO,12/29/2016,5/3/2017,125,0,0,0,0,0,0,Oncology,I/II,Closed,61,PPD," Brazil, Canada, Czechia, Denmark, France, Germany, Hungary, Italy, Russian Federation (the), Spain, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-8R8L,10/31/2017,1/29/2018,90,0,0,0,0,0,0,GI,III,Closed,2200,Quintiles," Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia, Denmark, Egypt, Estonia, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Korea (the Republic of), Latvia, Malaysia, Malta, Netherlands (the), New Zealand, Norway, Poland, Portugal, Romania, Russian Federation (the), Serbia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan (Province of China), Turkey, Ukraine, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-3ELU5B,4/19/2021,6/14/2021,56,0,0,0,0,0,0,CNS,I,Planned,24,PRA,NULL
1-9I7GV,12/15/2017,2/5/2018,52,0,0,0,0,0,0,Oncology,III,Closed,354,Quintiles," Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Egypt, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea (the Republic of), Lebanon, Lithuania, Malaysia, Mexico, Netherlands (the), New Zealand, Norway, Peru, Poland, Portugal, Puerto Rico, Romania, Russian Federation (the), Saudi Arabia, Serbia, Singapore, Slovakia, Spain, Sweden, Switzerland, Taiwan (Province of China), Thailand, Turkey, Ukraine, United Arab Emirates (the), United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-CK4HM,12/31/2017,3/4/2018,63,0,0,0,0,0,0,Oncology,I,Closed,95,Sarah Cannon Research Institut, United States of America (the)
1-994OP,2/27/2019,4/28/2019,60,0,0,0,0,0,0,Oncology,III,Enrollment Complete,248,PPD," Australia, Brazil, Canada, China, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea (the Republic of), Netherlands (the), Norway, Singapore, Spain, Sweden, Switzerland, Taiwan (Province of China), Thailand, Turkey, Ukraine, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-3ZP5KE,12/6/2006,1/31/2007,56,0,0,0,0,0,0,NULL,I/II,Planned,36,TBD, Japan
1-CP5PJ,2/28/2021,5/20/2021,81,1,0,0,1,0,0,Oncology,III,Execution,701,PPD," Belgium, Canada, France, Japan, Korea (the Republic of), New Zealand, Russian Federation (the), United States of America (the)"
1-9KB55,12/18/2012,1/17/2013,30,0,0,0,0,0,0,NULL,I,Closed,218,Hammersmith Medicines Research, United Kingdom of Great Britain and Northern Ireland (the)
1-8UPO,11/27/2017,10/1/2018,308,0,0,0,0,0,0,Oncology,I/II,Closed,60,PPD, United States of America (the)
1-ACL3H,4/4/2017,5/15/2017,41,0,0,0,0,0,0,Oncology,I,Closed,24,PPD," Hong Kong, Korea (the Republic of), Singapore"
1-1VZYMN ,6/15/2018,11/8/2018,146,0,0,0,0,0,0,GI,I,Closed,6,PRA, Netherlands (the)
1-CJRPD,2/7/2019,5/9/2019,91,0,0,0,0,0,0,Oncology,I,Closed,170,Synteract," Spain, United States of America (the)"
1-23H34T,10/26/2020,12/21/2020,56,0,0,0,0,0,0,GI,I,Planned,24,Celerion,NULL
1-Z9VLF,3/26/2021,5/13/2021,48,0,0,0,0,0,0,CNS,III,Cancelled,550,IQVIA, Canada
1-9H28T,1/28/2021,5/12/2021,104,0,0,0,0,0,0,Oncology,III,Enrollment Complete,1334,ICON," Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Croatia, Czechia, Denmark, France, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea (the Republic of), Mexico, Netherlands (the), New Zealand, Norway, Peru, Poland, Romania, Russian Federation (the), Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan (Province of China), Thailand, Turkey, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-10ELZC,1/31/2020,4/3/2020,63,0,0,0,0,0,0,Oncology,I,Closed,46,IQVIA," Japan, Korea (the Republic of)"
1-GG0OZ,6/30/2018,9/1/2018,63,0,0,0,0,0,0,Oncology,I,Closed,101,Quintiles," Spain, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-F6HHL,12/30/2019,2/28/2020,60,0,0,0,0,0,0,Oncology,IV,Closed,NULL,IQVIA," Austria, Belgium, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Netherlands (the), Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom of Great Britain and Northern Ireland (the)"
1-24REN3,11/30/2020,2/2/2021,64,1,0,0,1,0,0,Oncology,III,Completed,270,PRA," Australia, Austria, Canada, Czechia, Denmark, Finland, France, Germany, Hong Kong, Italy, Korea (the Republic of), Luxembourg, Netherlands (the), Norway, Portugal, Singapore, Spain, Sweden, Switzerland, Taiwan (Province of China), United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-26UPD0,6/19/2021,6/24/2021,5,1,0,0,0,0,0,Oncology,III,Enrolling,230,PRA," Argentina, Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia, Denmark, Finland, France, Greece, Hungary, Israel, Italy, Korea (the Republic of), Mexico, New Zealand, Norway, Poland, Romania, Russian Federation (the), Singapore, Slovakia, Spain, Taiwan (Province of China), Turkey, United States of America (the)"
1-IDSVB,5/30/2019,8/1/2019,63,0,0,0,0,0,0,Oncology,I,In Follow-Up,182,Quintiles," Belgium, Canada, Germany, Italy, Moldova (the Republic of), Spain, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-G14DR,5/21/2018,6/26/2018,36,0,0,0,0,0,0,Oncology,I,Closed,64,Quintiles, United States of America (the)
1-N61SX,4/19/2014,5/27/2014,38,0,0,0,0,0,0,NULL,I,Closed,40,In-House, United States of America (the)
1-ZA6XT,11/16/2015,12/23/2015,37,0,0,0,0,0,0,CNS,III,Closed,1750,PPD, United States of America (the)
1-ZD0TN,11/11/2019,12/16/2019,35,0,0,0,0,0,0,CNS,I,Hold,52,TBD,NULL
1-EGKBL,11/30/2018,1/15/2019,46,0,0,0,0,0,0,Oncology,I,Closed,64,PPD, United States of America (the)
1-JLM1X,1/5/2019,3/9/2019,63,0,0,0,0,0,0,Oncology,I/II,Closed,118,Quintiles," Belgium, France, United States of America (the)"
1-O0YDZ,12/31/2020,3/19/2021,78,0,0,0,0,0,0,Oncology,I/II,Enrollment Complete,67,Quintiles," Belgium, Brazil, Czechia, Hong Kong, Italy, Japan, Singapore, Spain, Taiwan (Province of China), United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-LSEIL,12/14/2015,3/28/2016,105,0,0,0,0,0,0,Oncology,II,Closed,100,Quintiles," United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-HTT6P,3/11/2020,5/30/2020,80,0,0,0,0,0,0,Oncology,IV,Closed,60,IQVIA," Belgium, Czechia, Germany, Hungary, Israel, Korea (the Democratic People's Republic of), Lithuania, Malaysia, Poland, Portugal, Russian Federation (the), Spain, Taiwan (Province of China), Thailand, Turkey, Ukraine, United States of America (the)"
1-V5BIE,2/17/2017,3/31/2017,42,0,0,0,0,0,0,Oncology,IB,Closed,178,Quintiles," Belgium, Italy, Poland, Spain, United States of America (the)"
1-RP5YP,9/4/2019,10/30/2019,56,0,0,0,0,0,0,Oncology,II,Enrollment Complete,120,PPD," Belgium, Brazil, Bulgaria, Canada, Czechia, France, Germany, Ireland, Israel, Italy, Netherlands (the), Spain, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-ZA6UK,5/9/2018,9/25/2018,139,0,0,0,0,0,0,CNS,III,Closed,149,Quintiles," Australia, Germany, Ireland, Italy, Russian Federation (the), Switzerland, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-INX3G,6/29/2018,7/31/2018,32,0,0,0,0,0,0,Oncology,II,Closed,148,PPD," Australia, Denmark, Greece, Hungary, New Zealand, Poland, Sweden, United States of America (the)"
1-ZA6WT,5/4/2015,6/19/2015,46,0,0,0,0,0,0,CNS,I,Closed,36,PPD, United States of America (the)
1-ZA6W2,3/2/2015,3/4/2015,2,0,0,0,0,0,0,CNS,I,Closed,11,In-House, United States of America (the)
1-MGEGX,6/5/2017,8/28/2017,84,0,0,0,0,0,0,Oncology,I,Closed,52,PPD, United States of America (the)
1-ZD0OZ,8/30/2016,11/16/2016,78,0,0,0,0,0,0,CNS,I,Closed,22,Quintiles, United Kingdom of Great Britain and Northern Ireland (the)
1-274PSD,11/28/2020,3/22/2021,114,0,0,0,0,0,0,Oncology,III,Enrollment Complete,44,INC Research," Argentina, Austria, Belgium, Canada, Czechia, Denmark, France, Germany, Hong Kong, Hungary, Israel, Italy, Korea (the Democratic People's Republic of), Korea (the Republic of), Netherlands (the), Norway, Poland, Portugal, Romania, Russian Federation (the), Singapore, Spain, Switzerland, United Kingdom of Great Britain and Northern Ireland (the)"
1-ZA6WK,4/13/2015,6/2/2015,50,0,0,0,0,0,0,CNS,I,Closed,36,PPD, United States of America (the)
1-ZD0RB,9/19/2019,10/31/2019,42,0,0,0,0,0,0,CNS,III,Cancelled,500,NULL,NULL
1-ZD7XX,4/27/2016,6/15/2016,49,0,0,0,0,0,0,CVM,I,Closed,24,PPD, Russian Federation (the)
1-ZA71K,3/7/2018,5/2/2018,56,0,0,0,0,0,0,GI,IIIB,Closed,100,Quintiles," Belgium, Canada, Czechia, France, Hungary, Italy, Poland, United States of America (the)"
1-ZD80O,4/29/2016,6/9/2016,41,0,0,0,0,0,0,CNS,I,Closed,74,PPD," United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-ZD0ST,3/11/2021,6/4/2021,85,0,0,0,0,0,0,CNS,II,Completed,234,IQVIA," Czechia, Germany, Italy, Poland, Russian Federation (the), Serbia, Spain, Ukraine, United States of America (the)"
1-10FGYU,4/10/2020,5/10/2020,30,0,0,0,0,0,0,Oncology,I,Cancelled,45,NULL,NULL
1-OH0W6,11/13/2015,4/27/2016,166,0,0,0,0,0,0,Oncology,II,Terminated,43,Quintiles," Belgium, Brazil, Italy, Peru, Spain, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-ZD7WM,10/21/2019,1/27/2020,98,0,0,0,0,0,0,NULL,IIIB,Cancelled,300,NULL,NULL
1-274PT2,7/31/2020,9/25/2020,56,0,0,0,0,0,0,Oncology,I,Planned,24,NULL,NULL
1-Z9VMJ,3/3/2020,4/21/2020,49,0,0,0,0,0,0,CNS,III,Cancelled,550,PRA,NULL
1-127563,10/26/2012,11/25/2012,30,0,0,0,0,0,0,Oncology,II,Planned,150,PPD,NULL
1-274PTB,2/14/2021,4/10/2021,55,0,0,0,0,0,0,Oncology,I,In Close Out,14,Celerion,NULL
1-ZA6X2,10/1/2015,11/9/2015,39,0,0,0,0,0,0,CNS,I,Closed,76,PPD, United States of America (the)
1-12MXSR,9/23/2019,11/18/2019,56,0,0,0,0,0,0,CNS,I,Closed,114,PPD, United States of America (the)
1-ZD8AP,10/27/2017,12/28/2017,62,0,0,0,0,0,0,CVM,III,Closed,600,Quintiles, China
1-274PU2,12/28/2020,3/15/2021,77,0,0,0,0,0,0,Oncology,I,Enrollment Complete,26,PRA," Australia, Netherlands (the), Singapore"
1-ZA70B,11/6/2020,1/1/2021,56,0,0,0,0,0,0,GI,II,Closed,80,PRA," Belgium, Canada, France, Germany, Hungary, Israel, Netherlands (the), Poland, Ukraine, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-ZD7ZJ,8/28/2014,8/13/2015,350,0,0,0,0,0,0,CNS,I,Closed,27,Covance, United States of America (the)
1-ZA722,9/28/2018,11/23/2018,56,0,0,0,0,0,0,GI,III,Closed,400,Quintiles," Argentina, Australia, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Colombia, Croatia, Czechia, Denmark, Estonia, Germany, Hungary, Israel, Italy, Japan, Korea (the Republic of), Lithuania, Mexico, Netherlands (the), Poland, Romania, Russian Federation (the), Serbia, Slovakia, Spain, Sweden, Turkey, Ukraine, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-ZF60Y,1/23/2021,3/21/2021,57,0,0,0,0,0,0,GI,IV,Start Up,60,Quintiles, United States of America (the)
SHP615-302,2/8/2021,3/22/2021,42,1,1,0,1,1,0,CNS,III,Completed,6,IQVIA, Japan
1-274PXX,9/2/2011,10/2/2011,30,0,0,0,0,0,0,Oncology,I,Planned,40,NULL,NULL
1-ZA7F5,11/17/2018,1/11/2019,55,0,0,0,0,0,0,CNS,I,Cancelled,36,NULL,NULL
SHP633-301,9/30/2020,10/14/2020,14,0,0,0,0,0,0,GI,III,Completed,10,IQVIA," Finland, France, Italy, United Kingdom of Great Britain and Northern Ireland (the)"
1-29750Q,1/5/2021,3/15/2021,69,0,0,0,0,0,0,Oncology,II,Cancelled,50,NULL,NULL
SHP639-101,5/30/2018,11/13/2018,167,0,0,0,0,0,0,Ophthalmology,I,Completed,84,PPD," Belgium, United States of America (the)"
1-ZD7ZX,3/12/2014,6/12/2014,92,0,0,0,0,0,0,CNS,I,Closed,18,Covance, Sweden
SHP647-302,7/15/2020,11/9/2020,117,0,0,0,0,0,0,GI,III,Completed,825,TBD," Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Colombia, Croatia, Czechia, Denmark, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Jordan, Kenya, Korea (the Republic of), Latvia, Lebanon, Lithuania, Malaysia, Mexico, Netherlands (the), New Zealand, Norway, Poland, Portugal, Romania, Russian Federation (the), Saudi Arabia, Serbia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Tunisia, Turkey, Ukraine, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the), Viet Nam"
1-ZD88J,12/31/2018,11/22/2019,326,0,0,0,0,0,0,GI,III,Closed,693,IQVIA," China, Korea (the Republic of), Malaysia, Taiwan (Province of China)"
1-2H721R,5/23/2019,6/17/2019,25,0,0,0,0,0,0,CNS,I,Closed,48,PRA, United States of America (the)
1-ZD88A,7/27/2017,9/1/2017,36,0,0,0,0,0,0,GI,III,Closed,480,Quintiles," China, Korea (the Republic of), Malaysia, Taiwan (Province of China)"
201501,10/9/2020,10/9/2020,0,0,0,0,1,0,0,RGH,I/II,Execution,10,IQVIA," Austria, Canada, France, Germany, Hungary, Italy, Japan, Poland, Spain, Sweden, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-ZD8CA,9/23/2017,10/20/2017,27,0,0,0,0,0,0,CNS,I,Closed,72,PPD, United Kingdom of Great Britain and Northern Ireland (the)
1-ZF5WP,7/16/2015,9/10/2015,56,0,0,0,0,0,0,CNS,I,Closed,48,PPD, United States of America (the)
241502,4/19/2021,6/1/2021,43,0,0,0,0,0,0,RGH,III,Cancelled,12,IQVIA," Bulgaria, Canada, Germany, Hungary, Italy, Netherlands (the), Norway, Poland, Russian Federation (the), Serbia, South Africa, Spain, Sweden, Taiwan (Province of China), Thailand, Turkey, Ukraine, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-ZF5X1,4/19/2016,6/17/2016,59,0,0,0,0,0,0,CNS,I,Closed,40,PPD, United States of America (the)
SHP615-301,10/15/2019,11/19/2019,35,0,0,0,0,0,0,CNS,III,Completed,25,IQVIA, Japan
SHP682-101,12/18/2020,2/26/2021,70,0,0,0,0,0,0,NULL,I,Closed,48,TBD,NULL
SHP621-303,4/30/2021,6/11/2021,42,0,0,0,0,0,0,GI,III,Execution,100,PPD, United States of America (the)
1-2TM0AN,5/16/2021,5/20/2021,4,0,0,0,0,0,0,Oncology,I,Enrolling,202,PRA," Belgium, China, Poland, Romania, Spain, Ukraine, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
SHP-GCB-702,3/31/2020,6/30/2020,91,0,0,0,0,0,0,NULL,Phase 4,"Active, Recruiting",150,NULL, Germany
1-30LDVL,4/20/2020,5/18/2020,28,0,0,0,0,0,0,GI,I,Cancelled,24,PRA,NULL
SHP633-305,5/28/2021,6/11/2021,14,0,0,0,0,0,0,GI,III,Execution,9,IQVIA, Japan
1-ZF60M,2/5/2019,4/4/2019,58,0,0,0,0,0,0,GI,IV,Closed,12,PPD, United States of America (the)
1-ZD8BA,3/19/2017,5/3/2017,45,0,0,0,0,0,0,CVM,I,Closed,64,Quintiles, China
TED-C13-003,1/9/2015,2/5/2015,27,0,0,0,0,0,0,GI,III,Completed,42,Psi," United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-14MLFD,9/29/2017,11/20/2017,52,0,0,0,0,0,0,CNS,I,Cancelled,40,IQVIA,NULL
DX-2930-03,4/13/2017,5/10/2017,27,0,0,0,0,0,0,RGH,III,Completed,120,IQVIA," Canada, Germany, Italy, Jordan, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
SHP633-306,8/16/2019,10/4/2019,49,0,0,0,0,0,0,GI,III,Completed,5,IQVIA, Japan
1-1DC20B,11/26/2020,1/5/2021,40,0,0,0,0,0,0,CNS,I,Terminated,16,PRA, United States of America (the)
1-ZOEFB,8/19/2016,11/7/2016,80,0,0,0,0,0,0,CNS,I,Closed,25,Quintiles,NULL
1-3414NB,4/28/2021,5/26/2021,28,0,0,0,0,0,0,Oncology,I,Planned,73,Celerion,NULL
HGT-HIT-094,9/28/2017,12/4/2017,67,0,0,0,0,0,0,RGH,III,Completed,48,PPD," Argentina, Australia, Canada, Colombia, France, Germany, Mexico, Spain, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
241302,6/7/2019,4/26/2021,689,0,0,0,0,0,0,RGH,IV,Completed,40,IQVIA, United States of America (the)
1-36QQJG,3/9/2021,4/6/2021,28,0,0,0,0,0,0,CNS,I,Planned,12,NULL,NULL
1-1EIAUN,6/5/2017,7/28/2017,53,0,0,0,0,0,0,GI,III,Closed,204,Quintiles, Mexico
SHP616-300,7/24/2017,8/23/2017,30,0,0,0,0,0,0,Plasma Derived Therapy,III,Completed,66,PPD," Canada, Germany, Hungary, Israel, Romania, Spain, United States of America (the)"
1-3A58P8,6/22/2020,7/20/2020,28,0,0,0,0,0,0,CNS,II,Closed,42,IQVIA, United States of America (the)
SHP621-102,12/29/2017,3/8/2018,69,0,0,0,0,0,0,GI,I,Completed,16,NULL, United States of America (the)
10201806006,3/16/2018,5/24/2018,69,0,0,0,0,0,0,CNS,III,Closed,492,EPS, Japan
DX-2930-04,11/4/2019,12/17/2019,43,0,0,0,0,0,0,RGH,III,Completed,250,"Red Maple Trials, Rho, Triumpharma"," Canada, Germany, Italy, Jordan, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-1EIAVJ,5/9/2018,7/15/2018,67,0,0,0,0,0,0,Oncology,IB,Closed,106,PRA, United States of America (the)
SHP633-302,1/21/2020,6/8/2020,139,0,0,0,0,0,0,GI,III,Completed,10,IQVIA, Japan
SHP634-102,6/26/2017,8/22/2017,57,0,0,0,0,0,0,RGH,I,Completed,24,Parexel, United States of America (the)
SHP640-301,6/4/2020,7/8/2020,34,0,0,0,0,0,0,Ophthalmology,III,Completed,540,IQVIA," Australia, Austria, Canada, Colombia, Estonia, France, Germany, Hungary, India, Israel, Italy, Peru, Philippines (the), Poland, South Africa, Spain, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
SHP643-101,5/30/2018,7/30/2018,61,0,0,0,0,0,0,RGH,I,Completed,32,PPD, United States of America (the)
SHP634-404,4/14/2020,12/17/2020,247,0,0,0,0,0,0,GI,IV,Closed,32,TBD," Canada, Denmark, Hungary, United States of America (the)"
SHP647-305,7/7/2020,11/30/2020,146,0,0,0,0,0,0,GI,III,Completed,1032,TBD," Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, China, Colombia, Croatia, Czechia, Denmark, Egypt, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Jordan, Kenya, Korea (the Republic of), Latvia, Lebanon, Lithuania, Malaysia, Mexico, Netherlands (the), New Zealand, Norway, Poland, Portugal, Romania, Russian Federation (the), Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Tunisia, Turkey, Ukraine, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the), Viet Nam"
SHP671-101,2/24/2021,3/17/2021,21,0,0,0,0,0,0,NULL,I,Study Withdrawn,10,NULL,NULL
TAK-620-1019,11/25/2019,3/3/2020,99,0,0,0,0,0,0,RGH,I,Study Terminated,38,PPD, United States of America (the)
TAK-888-2001,3/10/2021,3/28/2021,18,0,0,0,0,0,0,Plasma Derived Therapy,III,Study Withdrawn,500,NULL,NULL
SPD489-348,1/3/2020,1/30/2020,27,0,0,0,0,0,0,CNS,III,Completed,100,PPD," Canada, United States of America (the)"
TED-C14-006,7/28/2017,10/20/2017,84,0,0,0,0,0,0,GI,III,Completed,34,IQVIA," Belgium, Canada, Finland, France, Germany, Italy, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
VV_DEN_204,2/18/2019,8/1/2019,164,0,0,0,0,0,0,Vaccine,IIa,Completed,1800,IQVIA," Colombia, Dominican Republic (the), Panama, Philippines (the), Thailand"
VV_DEN_203-2,4/1/2016,12/30/2016,273,0,0,0,0,0,0,Vaccine,IIa,Closed,360,Chiltern," Colombia, Puerto Rico, Singapore, Thailand"
VV_DEN_315,1/28/2019,5/8/2019,100,0,0,0,0,0,0,NULL,Phase III,Closed,400,PPD, Mexico
VV_NOR_211,6/16/2018,8/8/2018,53,0,0,0,0,0,0,NULL,Phase IIb,Completed,4176,IQVIA, United States of America (the)
1-3CYXNM,7/14/2020,8/11/2020,28,0,0,0,0,0,0,CNS,I,Cancelled,8,Celerion,NULL
1-3CYXSU,9/1/2015,10/7/2015,36,0,0,0,0,0,0,CNS,I,Planned,36,Celerion, United States of America (the)
1-3CYXTC,11/6/2020,12/11/2020,35,0,0,0,0,0,0,CNS,I,Planned,24,NULL,NULL
1-3CYXVW,9/1/2015,10/7/2015,36,0,0,0,0,0,0,CNS,I,Planned,20,Celerion, United States of America (the)
91301,2/28/2020,8/31/2020,185,0,0,0,0,0,0,RGH,IV,Completed,55,Synteract," Austria, Belgium, France, Germany, Hungary, Italy, Netherlands (the), Norway, Poland, Portugal, Russian Federation (the), Spain, Sweden, Turkey, United Kingdom of Great Britain and Northern Ireland (the)"
1-3CYXWK,8/12/2020,9/9/2020,28,0,0,0,0,0,0,CNS,I,Cancelled,96,PRA,NULL
1-3CYXXD,9/22/2020,10/27/2020,35,0,0,0,0,0,0,CNS,I,Planned,16,TBD,NULL
1-3DYCDM,5/16/2021,6/25/2021,40,0,0,0,0,0,0,GI,I,Enrolling,40,Celerion, United States of America (the)
10201806029,6/19/2019,2/3/2020,229,0,0,0,0,0,0,CNS,I,Closed,40,Takeda PRA Development Center, Japan
1-8ULV,5/23/2017,6/30/2017,38,0,0,0,0,0,0,NULL,I,Closed,63,Quintiles, United States of America (the)
10201810001,1/10/2021,3/21/2021,70,0,0,0,0,0,0,Oncology,II,Cancelled,15,TBD, Japan
1-HRYDH,9/30/2015,6/20/2017,629,0,0,0,0,0,0,Oncology,I,Terminated,20,PPD, United States of America (the)
1-1026F0,5/1/2019,6/28/2019,58,0,0,0,0,0,0,CNS,IV,Closed,1100,Quintiles, United States of America (the)
1-106L20,1/21/2014,3/13/2014,51,0,0,0,0,0,0,NULL,II,Closed,104,NULL,NULL
1-10ELQ6,9/30/2020,11/6/2020,37,0,0,0,0,0,0,Oncology,I/II,In Close Out,142,PRA, Japan
1-10ELQX,11/12/2020,12/12/2020,30,0,0,0,0,0,0,Oncology,II,Cancelled,150,NULL,NULL
1-O1BUN,8/12/2019,1/30/2021,537,0,0,0,0,0,0,Oncology,III,Enrollment Complete,706,PPD," Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea (the Republic of), Mexico, Poland, Portugal, Russian Federation (the), Serbia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan (Province of China), Thailand, Turkey, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-ZA6XK,9/28/2015,11/4/2015,37,0,0,0,0,0,0,CNS,II,Closed,200,PPD, United States of America (the)
1-ZA72B,3/12/2021,6/8/2021,88,0,0,0,0,0,0,GI,IIIB,Enrollment Complete,746,Quintiles," Argentina, Australia, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Colombia, Croatia, Czechia, Denmark, Estonia, Germany, Hungary, Israel, Italy, Japan, Korea (the Republic of), Lithuania, Mexico, Netherlands (the), Poland, Romania, Russian Federation (the), Serbia, Slovakia, South Africa, Spain, Sweden, Taiwan (Province of China), Turkey, Ukraine, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-ZD863,4/14/2021,6/10/2021,57,0,0,0,0,0,0,GI,II,Planned,70,IQVIA," Belgium, Brazil, Bulgaria, Colombia, France, Germany, Hungary, Israel, Italy, Korea (the Republic of), Lithuania, Mexico, Poland, Portugal, Ukraine, United States of America (the)"
1-ZF5Z0,8/4/2014,10/14/2014,71,0,0,0,0,0,0,CNS,II,Closed,120,Covance, United States of America (the)
PAR-C10-008,1/30/2018,7/3/2018,154,0,0,0,0,0,0,RGH,III,Completed,40,Medpace, United States of America (the)
SHP465-112,10/5/2018,11/16/2018,42,0,0,0,0,0,0,CNS,I,Completed,24,PPD, United States of America (the)
SHP634-101,3/8/2019,2/17/2020,346,0,0,0,0,0,0,RGH,I,Completed,34,PPD," Canada, Denmark, Hungary, Korea (the Republic of), United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
SHP634-104,2/25/2021,3/26/2021,29,0,0,0,0,0,0,GI,I,Closed,14,PPD," Finland, France, Israel, Lithuania, Portugal, Slovenia, Spain, United Kingdom of Great Britain and Northern Ireland (the)"
SHP634-401,1/18/2021,3/17/2021,58,0,0,0,0,0,0,GI,IV,Execution,92,PPD," Belgium, Canada, Denmark, France, Germany, Italy, Korea (the Republic of), Netherlands (the), Norway, Portugal, Spain, Sweden, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
SHP640-302,12/31/2019,2/14/2020,45,0,0,0,0,0,0,Ophthalmology,III,Completed,284,IQVIA," India, Philippines (the), Puerto Rico, United States of America (the)"
SHP640-303,10/3/2018,11/15/2018,43,0,0,0,0,0,0,Ophthalmology,III,Completed,721,IQVIA," Australia, Austria, Canada, Colombia, Estonia, France, Germany, Hungary, India, Israel, Italy, Peru, Philippines (the), Poland, Puerto Rico, South Africa, Spain, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
SHP-GCB-402,2/1/2021,4/30/2021,88,0,0,0,0,0,0,RGH,IV,Completed,19,TBD," Australia, Austria, Canada, Germany, Israel, Italy, Portugal, Spain, Turkey, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
SHPGCB-703,12/16/2019,1/15/2020,30,0,0,0,0,0,0,NULL,Phase 4,"Active, Recruiting",45,NULL, France
TAK-073-1501,1/30/2020,1/30/2020,0,0,0,0,0,0,0,RGH,I/II,Stopped,8,PPD, United States of America (the)
VV_DEN_205,9/18/2017,1/11/2018,115,0,0,0,0,0,0,NULL,Phase IIa,Closed,400,PPD, Singapore
VV_DEN_304,1/14/2019,5/22/2019,128,0,0,0,0,0,0,NULL,Phase III,Closed,924,PPD, United States of America (the)
VV_DEN_313,10/28/2020,5/7/2021,191,0,0,0,0,0,0,NULL,Phase II,Execution,200,PPD," Panama, Philippines (the)"
VV_DEN_314,7/9/2019,10/2/2019,85,0,0,0,0,0,0,NULL,Phase IIIa,Closed,900,PPD, United Kingdom of Great Britain and Northern Ireland (the)
1-10FGX3,3/30/2021,5/15/2021,46,0,0,0,0,0,0,Oncology,II,Completed,122,PRA," Canada, France, Germany, Italy, Spain, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-10FH0N,2/13/2021,3/15/2021,30,0,0,0,0,0,0,Oncology,I,Cancelled,25,NULL,NULL
1-10FLG7,12/11/2018,12/25/2018,14,0,0,0,0,0,0,Oncology,I,Closed,8,PRA, Hungary
1-12754G,11/3/2020,1/5/2021,63,0,0,0,0,0,0,NULL,I,Cancelled,175,PPD,NULL
1-127574,10/21/2013,11/20/2013,30,0,0,0,0,0,0,Oncology,II,Planned,150,PPD,NULL
1-12MTGF,3/1/2021,5/31/2021,91,0,0,0,0,0,0,GI,IV,Execution,300,Univ. California San Diego," Canada, United States of America (the)"
1-13KZLX,11/29/2019,4/6/2020,129,0,0,0,0,0,0,Oncology,II,Enrollment Complete,141,GEICAM," Spain, United States of America (the)"
1-17X9H9,9/10/2018,10/5/2018,25,0,0,0,0,0,0,GI,I,Closed,16,PRA, China
1-17X9I5,9/10/2020,1/30/2021,142,0,0,0,0,0,0,GI,III,Execution,204,IQVIA, China
1-1BKVJT,1/21/2020,2/21/2020,31,0,0,0,0,0,0,Oncology,III,Execution,40,PPD, Korea (the Republic of)
1-1BKVML,1/20/2021,2/18/2021,29,0,0,0,0,0,0,Oncology,I,In Follow-Up,22,Quintiles," Japan, Korea (the Republic of)"
1-1CJZC7,5/21/2020,7/23/2020,63,0,0,0,0,0,0,GI,III,Terminated,830,Quintiles," China, Hong Kong, India, Korea (the Republic of), Malaysia, Philippines (the), Russian Federation (the), Taiwan (Province of China), Thailand"
1-1CJZCH,6/7/2019,9/5/2019,90,0,0,0,0,0,0,GI,III,Closed,530,IQVIA," China, India, Korea (the Democratic People's Republic of), Malaysia, Philippines (the), Russian Federation (the), Taiwan (Province of China)"
1-1MI4EK,4/23/2021,5/23/2021,30,0,0,0,0,0,0,Oncology,I,Cancelled,30,Quintiles,NULL
1-1P9TDT,12/25/2019,2/19/2020,56,0,0,0,0,0,0,NULL,0,Cancelled,100,NULL,NULL
1-1VZYOK,8/15/2019,9/6/2019,22,0,0,0,0,0,0,GI,I,Closed,32,PRA," Czechia, Hungary"
1-1W19SY,6/10/2021,6/18/2021,8,0,0,0,0,0,0,GI,I,Planned,48,Celerion,NULL
1-25CUP8,11/23/2020,1/19/2021,57,0,0,0,0,0,0,GI,I,Planned,24,PRA,NULL
1-2LTMMZ ,5/1/2020,5/29/2020,28,0,0,0,0,0,0,CNS,I,Cancelled,6,Celerion, United States of America (the)
1-2UGJFT,11/26/2020,12/24/2020,28,0,0,0,0,0,0,CNS,III,Planned,400,NULL, United States of America (the)
1-2UGJKW,2/17/2020,3/26/2020,38,0,0,0,0,0,0,CNS,I,On Hold,40,NULL,NULL
1-3CYXQQ,9/8/2020,10/6/2020,28,0,0,0,0,0,0,CNS,I,Planned,40,TBD,NULL
1-3CYXYO,4/17/2021,6/7/2021,51,0,0,0,0,0,0,CNS,I,Planned,48,TBD,NULL
1-3D8NXM,6/4/2021,6/22/2021,18,0,0,0,0,0,0,RGH,II,Enrolling,36,PPD," Belgium, Canada, Italy, Poland, Serbia, Spain, United States of America (the)"
1-3D8O5D,3/1/2021,4/19/2021,49,0,0,0,0,0,0,CNS,IB,Planned,28,NULL,NULL
1-3ELU4T,12/24/2020,2/18/2021,56,0,0,0,0,0,0,CNS,I,Planned,24,TBD,NULL
1-3ELUA3,5/14/2021,6/11/2021,28,0,0,0,0,0,0,NULL,IB,Cancelled,30,NULL,NULL
1-3G1MUN,5/4/2021,6/10/2021,37,0,0,0,0,0,0,CNS,0,Enrolling,32,Quintiles, United States of America (the)
1-8UOZ,11/13/2018,12/13/2018,30,0,0,0,0,0,0,Oncology,I,Closed,32,ICON," Argentina, Canada, France, Germany, Greece, Hungary, Italy, Netherlands (the), Norway, Spain, Sweden, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-8VE85,2/15/2012,3/16/2012,30,0,0,0,0,0,0,NULL,I,Closed,89,PPD, United States of America (the)
1-F29M,10/20/2014,12/20/2014,61,0,0,0,0,0,0,Oncology,I,Closed,34,Dobbs Consulting," Canada, United States of America (the)"
1-F2HL,7/27/2018,10/17/2018,82,0,0,0,0,0,0,Oncology,III,Closed,136,ICON," Argentina, Australia, Austria, Belgium, Brazil, Canada, Denmark, France, Germany, Hungary, Italy, Netherlands (the), Peru, Poland, Spain, Switzerland, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-HC2H3,3/25/2015,5/19/2015,55,0,0,0,0,0,0,Oncology,I,Closed,45,PPD, United States of America (the)
1-L6PF9,3/7/2017,5/24/2017,78,0,0,0,0,0,0,Oncology,II,Closed,125,Quintiles," Canada, United States of America (the)"
1-L7IAF,2/28/2019,3/25/2019,25,0,0,0,0,0,0,Oncology,I,Closed,30,Quintiles, United States of America (the)
1-OH0VT,10/23/2015,3/28/2016,157,0,0,0,0,0,0,Oncology,II,Cancelled,38,IQVIA," Belgium, Brazil, Italy, Peru, Spain, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-1L0NQP,7/26/2019,9/20/2019,56,0,0,0,0,0,0,Oncology,IIA,Closed,17,Quintiles," Belgium, France, Norway, Sweden, United States of America (the)"
1-P2K8B,10/8/2015,1/12/2016,96,0,0,0,0,0,0,Oncology,I/II,Cancelled,95,IQVIA," Japan, Korea (the Democratic People's Republic of), Taiwan (Province of China)"
1-ZA6YK,9/30/2018,1/30/2019,122,0,0,0,0,0,0,GI,IV,Closed,100,Hangzhou Tigermed Consulting, China
1-ZA774,7/22/2018,9/10/2018,50,0,0,0,0,0,0,CNS,I,Cancelled,6,TBD,NULL
1-ZA77D,12/6/2018,1/25/2019,50,0,0,0,0,0,0,CNS,I,Cancelled,70,NULL,NULL
1-1YQUIR,4/16/2021,5/21/2021,35,0,0,0,0,0,0,Oncology,IB,In Follow-Up,53,PRA," Canada, Germany, United States of America (the)"
1-ZD0Q2,2/27/2019,4/10/2019,42,0,0,0,0,0,0,CNS,II,Closed,65,Quintiles, United States of America (the)
1-22AXI5,3/1/2021,4/26/2021,56,0,0,0,0,0,0,Oncology,I,Execution,117,PRA, United States of America (the)
1-ZD0UF,9/23/2019,11/18/2019,56,0,0,0,0,0,0,CNS,I,Closed,16,Celerion, United States of America (the)
1-ZD7VH,11/22/2013,3/10/2014,108,0,0,0,0,0,0,CVM,I,Closed,48,Covance,NULL
1-25FRSE,9/3/2019,12/24/2019,112,0,0,0,0,0,0,NULL,IIIB,Closed,366,Atlant," Belarus, Georgia, Kazakhstan, Russian Federation (the), Ukraine"
1-ZD85G,3/19/2021,5/14/2021,56,0,0,0,0,0,0,GI,I,Cancelled,24,Quintiles," Israel, Italy, Mexico, Poland, United States of America (the)"
1-274PUB,12/17/2020,2/15/2021,60,0,0,0,0,0,0,Oncology,I,Cancelled,18,NULL,NULL
1-274PUK,5/7/2021,6/4/2021,28,0,0,0,0,0,0,Oncology,I,Execution,24,Celerion, United States of America (the)
1-2FHCAF,4/1/2021,5/31/2021,60,0,0,0,0,0,0,Oncology,I/II,Enrolling,52,PPD, United States of America (the)
1-2H721I,7/6/2020,11/30/2020,147,0,0,0,0,0,0,Oncology,II,Enrollment Complete,103,PRA," Australia, Austria, Canada, China, France, Germany, Hong Kong, Italy, Japan, Korea (the Republic of), Netherlands (the), Spain, Sweden, Taiwan (Province of China), United States of America (the)"
1-2IFHJV,8/24/2018,10/5/2018,42,0,0,0,0,0,0,GI,I,Closed,24,Celerion, United States of America (the)
1-2LTMO1,7/22/2019,9/16/2019,56,0,0,0,0,0,0,CNS,I,Cancelled,24,NULL, Japan
1-2NGAYV,3/4/2021,5/19/2021,76,0,0,0,0,0,0,GI,III,Enrolling,425,PPD, China
1-2PJ2LB,9/4/2020,10/4/2020,30,0,0,0,0,0,0,CNS,IB,Enrolling,16,PPD, United States of America (the)
1-2YLIZL,2/15/2021,3/15/2021,28,0,0,0,0,0,0,CNS,II,Completed,30,PPD, United States of America (the)
1-304JYV,12/6/2018,1/31/2019,56,0,0,0,0,0,0,GI,0,Completed,14,Parexel, United States of America (the)
1-30EP0F,2/7/2019,2/26/2019,19,0,0,0,0,0,0,CNS,0,Cancelled,40,NULL, United States of America (the)
1-31OP17,1/18/2021,2/15/2021,28,0,0,0,0,0,0,CNS,II,Cancelled,70,NULL,NULL
1-34Q1ZH,11/14/2019,12/12/2019,28,0,0,0,0,0,0,NULL,I,Cancelled,228,NULL,NULL
1-34WP2F,6/3/2021,6/10/2021,7,0,0,0,0,0,0,CNS,II,Cancelled,80,PPD,NULL
1-36QR0J,11/13/2020,1/8/2021,56,0,0,0,0,0,0,CNS,I,Planned,12,TBD,NULL
1-3CYXU4,9/21/2016,10/26/2016,35,0,0,0,0,0,0,CNS,I,Planned,32,NULL,NULL
1-3CYXXM,5/9/2021,6/11/2021,33,0,0,0,0,0,0,CNS,I,Planned,24,NULL,NULL
1-3CYXZG,1/27/2014,3/4/2014,36,0,0,0,0,0,0,CNS,III,Planned,48,NULL,NULL
1-3CYY1G,3/9/2021,4/6/2021,28,0,0,0,0,0,0,CNS,I,Planned,16,NULL,NULL
1-8UMZ,2/21/2018,3/19/2018,26,0,0,0,0,0,0,Oncology,I/II,Closed,61,PPD, United States of America (the)
1-9HF2D,9/30/2020,11/6/2020,37,1,1,0,1,1,0,Oncology,III,Enrollment Complete,722,PPD," Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, Denmark, France, Germany, Hong Kong, Hungary, Israel, Italy, Japan, Korea (the Republic of), Mexico, Netherlands (the), New Zealand, Poland, Portugal, Romania, Russian Federation (the), Singapore, Spain, Sweden, Taiwan (Province of China), Thailand, Turkey, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-DT93H,11/18/2016,1/25/2017,68,0,0,0,0,0,0,Oncology,I,Closed,40,ICON," Canada, United States of America (the)"
1-EEZ99,3/23/2017,6/12/2017,81,0,0,0,0,0,0,Oncology,II,Closed,44,PPD," Belgium, Canada, Italy, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-F28N,4/20/2012,5/24/2012,34,0,0,0,0,0,0,Oncology,I,Closed,116,Dobbs Consulting," Canada, United States of America (the)"
1-ZD87D,11/10/2014,12/18/2014,38,0,0,0,0,0,0,GI,II,Closed,63,Quintiles," Belgium, Brazil, Bulgaria, France, Hungary, Italy, Mexico, Poland, Portugal, United States of America (the)"
1-F2HY,3/30/2018,5/18/2018,49,0,0,0,0,0,0,Oncology,I,Closed,150,Quintiles," United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-ZD87X,8/18/2017,10/9/2017,52,0,0,0,0,0,0,GI,I,Closed,36,Quintiles, China
1-ZOEF2,5/4/2017,7/25/2017,82,0,0,0,0,0,0,CNS,I,Closed,128,Quintiles, United States of America (the)
251602,4/21/2021,5/21/2021,30,0,0,0,0,0,0,NULL,Phase 4,Enrolment Completed,25,IQVIA India, India
1-F9CI7,6/16/2015,8/14/2015,59,0,0,0,0,0,0,Oncology,I,Closed,20,ICON," Belgium, Lithuania, Netherlands (the), Spain, United Kingdom of Great Britain and Northern Ireland (the)"
1-OMAA5,12/31/2020,1/30/2021,30,0,0,0,0,0,0,Oncology,III,Execution,115,PPD, China
SHP616-301,5/4/2017,6/1/2017,28,0,0,0,0,0,0,Plasma Derived Therapy,III,Completed,12,Chiltern," Germany, Israel, Mexico, Romania, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-P37UL,9/30/2019,3/30/2020,182,0,0,0,0,0,0,Oncology,IB,Closed,81,Quintiles," France, Spain, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
SHP620-303,9/29/2020,11/13/2020,45,0,0,0,0,0,0,RGH,III,Completed,351,PPD," Australia, Austria, Belgium, Canada, Croatia, Czechia, Denmark, France, Germany, Italy, Korea (the Republic of), Netherlands (the), Poland, Singapore, Spain, Sweden, Switzerland, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
SHP634-103,11/3/2017,3/9/2018,126,0,0,0,0,0,0,RGH,I,Completed,58,"Clinical Pharmacology of Miami, INC", United States of America (the)
1-QCXSG,10/30/2020,2/8/2021,101,0,0,0,0,0,0,Oncology,II,Closed,242,PRA," Australia, Belgium, Canada, France, Germany, Italy, Netherlands (the), Norway, Spain, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
SHP643-102,11/18/2019,1/9/2020,52,0,0,0,0,0,0,RGH,I,Completed,190,PPD, United States of America (the)
TAK-743-1003,12/16/2020,2/1/2021,47,0,0,0,0,0,0,Plasma Derived Therapy,I,Completed,12,Celerion, United States of America (the)
1-ZA6U1,8/8/2019,9/26/2019,49,0,0,0,0,0,0,CNS,III,Closed,3500,Quintiles," Australia, Germany, Switzerland, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
VV_DEN_301,1/7/2019,4/2/2019,85,1,1,0,1,1,0,NULL,Phase IIIa,Execution,20100,PPD," Brazil, Colombia, Dominican Republic (the), Nicaragua, Panama, Philippines (the), Sri Lanka, Thailand"
1-ZA6UB,12/18/2014,3/18/2015,90,0,0,0,0,0,0,CNS,III,Closed,675,Covance," Italy, Russian Federation (the), Switzerland"
VV_DEN_307,3/20/2020,12/15/2020,270,0,0,0,0,0,0,NULL,Phase IIIa,Completed,200,IQVIA, United States of America (the)
VV_DEN_310,1/3/2020,1/10/2020,7,0,0,0,0,0,0,NULL,Phase IIIa,Planned,900,PPD,NULL
VV_NOR_204,9/29/2017,2/5/2018,129,0,0,0,0,0,0,NULL,Phase IIa,Completed,325,PPD, United States of America (the)
1-ZA71B,1/19/2019,3/15/2019,55,0,0,0,0,0,0,GI,IIIB,Closed,758,Quintiles," Argentina, Australia, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Colombia, Croatia, Czechia, Denmark, Estonia, France, Germany, Hong Kong, Hungary, Israel, Italy, Korea (the Republic of), Latvia, Lithuania, Mexico, Netherlands (the), Poland, Portugal, Romania, Russian Federation (the), Serbia, Slovakia, Spain, Taiwan (Province of China), Turkey, Ukraine, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
VV_ZIK_101,11/24/2020,6/14/2021,202,1,0,0,1,0,0,Vaccine,I,Execution,240,PRA Health Sciences," Puerto Rico, United States of America (the)"
1-ZD0NM,6/9/2016,10/12/2016,125,0,0,0,0,0,0,CNS,I,Closed,120,Quintiles, United Kingdom of Great Britain and Northern Ireland (the)
1-ZD0UY,5/24/2017,7/24/2017,61,0,0,0,0,0,0,CNS,I,Closed,16,PRA, United States of America (the)
1-ZD7XO,10/5/2015,6/29/2016,268,0,0,0,0,0,0,CVM,III,Closed,659,Covance," China, Korea (the Republic of), Malaysia, Taiwan (Province of China)"
1-ZF5YO,9/3/2013,12/9/2013,97,0,0,0,0,0,0,CNS,II,Closed,300,Covance, United States of America (the)
1-ZYOC0,2/6/2017,2/13/2017,7,0,0,0,0,0,0,CNS,0,Cancelled,150,In-House, United States of America (the)
251501,4/5/2019,4/30/2019,25,0,0,0,0,0,0,NULL,Phase 4,Completed - CSR Available,50,NULL, Korea (the Republic of)
471101,8/31/2020,11/9/2020,70,0,0,0,0,0,0,Plasma Derived Therapy,IV,Completed,36,IQVIA," Australia, Canada, New Zealand, United States of America (the)"
CS03,10/2/2017,11/30/2017,59,0,0,0,0,0,0,NULL,IV,Completed,50,Clinsupport," Austria, Germany"
SHP621-101,11/26/2017,1/22/2018,57,0,0,0,0,0,0,GI,I,Completed,22,NULL,NULL
SHP621-302,11/29/2019,12/27/2019,28,0,0,0,0,0,0,GI,III,Completed,200,PPD," Canada, United States of America (the)"
SHP633-303,7/14/2020,10/9/2020,87,0,0,0,0,0,0,GI,III,Completed,39,IQVIA," United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
SHP633-304,11/30/2020,1/25/2021,56,0,0,0,0,0,0,GI,III,Completed,57,TBD," Belgium, Canada, Finland, France, Germany, Italy, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
SHP684-101,12/15/2020,1/19/2021,35,0,0,0,0,0,0,Plasma Derived Therapy,I,Closed,166,TBD,NULL
SHPELA-701,11/30/2020,12/9/2020,9,0,0,0,0,0,0,RGH,IV,Completed,25,IQVIA, Mexico
TAK-743-1002,3/3/2021,4/7/2021,35,0,0,0,0,0,0,RGH,I,Study Terminated,24,IQVIA, United States of America (the)
VV_DEN_109,6/26/2020,8/21/2020,56,0,0,0,0,0,0,NULL,Phase IIa,Cancelled,90,PPD, United States of America (the)
VV_DEN_302,1/3/2020,1/10/2020,7,0,0,0,0,0,0,NULL,Phase II,Planned,450,PPD,NULL
VV_DEN_305,5/13/2019,11/4/2019,175,0,0,0,0,0,0,NULL,Phase III,Closed,900,PPD, United States of America (the)
VV_NOR_202,6/20/2018,8/30/2018,71,0,0,0,0,0,0,NULL,Phase IIa,Completed,840,IQVIA," Colombia, Finland, Panama"
10201806022,4/24/2018,6/18/2018,55,0,0,0,0,0,0,CVM,III,Closed,107,A2 Healthcare, Japan
1-10ELJS,5/17/2015,6/15/2015,29,0,0,0,0,0,0,NULL,I,Cancelled,50,TBD,NULL
1-10FGY3,3/4/2021,4/3/2021,30,0,0,0,0,0,0,Oncology,I/II,Cancelled,160,NULL,NULL
1-10FHKN,2/3/2020,10/30/2020,270,0,0,0,0,0,0,Oncology,II,In Close Out,30,Quintiles, China
1-12759X,11/28/2018,12/26/2018,28,0,0,0,0,0,0,Oncology,III,Planned,400,PPD,NULL
1-13KZMH,6/9/2017,7/31/2017,52,0,0,0,0,0,0,CNS,IV,Closed,352,Quintiles, United States of America (the)
1-1DC1ZT,8/7/2020,9/28/2020,52,0,0,0,0,0,0,CNS,I,Cancelled,30,NULL,NULL
1-1FQORY,3/31/2020,5/5/2020,35,0,0,0,0,0,0,CNS,I,Cancelled,60,NULL, United States of America (the)
1-1FQOVB,3/29/2019,4/30/2019,32,0,0,0,0,0,0,GI,III,Cancelled,450,Hangzhou Tigermed Consulting,NULL
1-1GDNNZ,7/13/2018,10/8/2018,87,0,0,0,0,0,0,CVM,I,Closed,72,Atlant, Russian Federation (the)
1-1HVXQ3,7/29/2018,8/24/2018,26,0,0,0,0,0,0,GI,I,Closed,24,Celerion, United States of America (the)
1-1KXHXR,4/15/2020,6/10/2020,56,0,0,0,0,0,0,GI,I,Planned,18,TBD,NULL
1-1MZ2O7,10/30/2018,12/5/2018,36,0,0,0,0,0,0,CNS,IIA,Closed,18,PRA, United States of America (the)
1-1VZYOB,9/28/2020,10/26/2020,28,0,0,0,0,0,0,GI,I,Cancelled,36,Celerion, United States of America (the)
1-1X3FRR,2/4/2021,3/25/2021,49,0,0,0,0,0,0,CNS,II,Completed,40,PRA," United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-23H34P,2/10/2021,3/10/2021,28,0,0,0,0,0,0,GI,I,Planned,24,Celerion,NULL
1-24RELX,11/30/2020,2/1/2021,63,0,0,0,0,0,0,Oncology,I/II,Enrolling,319,PRA," China, France, Germany, Italy, Japan, Korea (the Democratic People's Republic of), Spain, Taiwan (Province of China), United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-26UP5I,12/15/2019,1/15/2020,31,0,0,0,0,0,0,GI,0,Closed,20,PRA, United States of America (the)
1-26UPF5,1/30/2019,3/31/2019,60,0,0,0,0,0,0,Oncology,II,Closed,449,INC Research," Australia, Belgium, Canada, France, Germany, Italy, Korea (the Republic of), Netherlands (the), Singapore, Spain, Sweden, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-274PTT,12/1/2020,1/23/2021,53,0,0,0,0,0,0,Oncology,I,Enrolling,63,PRA, Japan
1-274Q4X,10/6/2020,11/5/2020,30,0,0,0,0,0,0,Oncology,Phase 1,Closed,28,Celerion, United States of America (the)
1-2LTMNS,12/16/2020,2/10/2021,56,0,0,0,0,0,0,CNS,I,Planned,48,Celerion, United States of America (the)
1-2PZXG5,10/11/2020,12/4/2020,54,0,0,0,0,0,0,CNS,II,Cancelled,24,PRA,NULL
1-2RLYB1,12/9/2020,1/19/2021,41,0,0,0,0,0,0,CNS,II,In Close Out,124,PPD," Australia, Canada, Israel, Poland, Spain, United States of America (the)"
1-2YDS7R,12/3/2020,12/31/2020,28,0,0,0,0,0,0,CNS,II,Cancelled,52,PRA, United States of America (the)
1-32C6FX,2/16/2021,3/16/2021,28,0,0,0,0,0,0,GI,IIA,Enrolling,100,PPD, United States of America (the)
1-33RHUL,5/5/2021,6/24/2021,50,0,0,0,0,0,0,CNS,I,Cancelled,24,TBD,NULL
1-382WX7,6/25/2020,9/23/2020,90,0,0,0,0,0,0,CNS,I,Enrollment Complete,6,Celerion, United States of America (the)
1-3BD3YR,11/19/2019,1/6/2020,48,0,0,0,0,0,0,GI,I,Closed,12,Celerion, United States of America (the)
1-3BD4B4,5/30/2015,8/10/2015,72,0,0,0,0,0,0,CNS,II,Planned,300,NULL,NULL
1-3CYXU9,9/1/2015,10/7/2015,36,0,0,0,0,0,0,CNS,I,Planned,36,Celerion, United States of America (the)
1-3CYXUI,8/9/2015,9/14/2015,36,0,0,0,0,0,0,CNS,I,Planned,36,Celerion, United States of America (the)
1-3CYXUW,9/21/2016,10/26/2016,35,0,0,0,0,0,0,CNS,I,Planned,48,TBD,NULL
1-3CYXYF,10/2/2020,11/23/2020,52,0,0,0,0,0,0,CNS,I,Planned,64,NULL,NULL
1-3DYCND,12/18/2020,1/15/2021,28,0,0,0,0,0,0,GI,I,Cancelled,24,NULL,NULL
1-3SDL33,12/31/2020,2/12/2021,43,0,0,0,0,0,0,CNS,I,Closed,18,PRA, United States of America (the)
1-3T436Z,10/7/2020,11/4/2020,28,0,0,0,0,0,0,GI,I,Planned,25,NULL,NULL
1-8VE8X,7/15/2013,9/30/2013,77,0,0,0,0,0,0,Oncology,I,Closed,99,PPD, United States of America (the)
1-9GYS5,4/12/2018,6/4/2018,53,0,0,0,0,0,0,Oncology,I/II,Closed,42,ICON," France, Germany, Italy, Mexico, Netherlands (the), Spain, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-F9CII,10/12/2020,12/2/2020,51,0,0,0,0,0,0,Oncology,IV,Enrollment Complete,49,Quintiles," Australia, Belgium, Bulgaria, Croatia, Czechia, Hungary, Israel, Poland, Portugal, Romania, Russian Federation (the), South Africa, Spain, Turkey, United Kingdom of Great Britain and Northern Ireland (the)"
1-HTWUL,1/31/2016,4/8/2016,68,0,0,0,0,0,0,Oncology,II,Closed,166,Quintiles," Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Poland, Spain, United States of America (the)"
1-HXXOT,11/9/2016,2/27/2017,110,0,0,0,0,0,0,Oncology,I,Cancelled,119,PPD," France, United States of America (the)"
1-U0EGW,6/29/2018,9/1/2018,64,0,0,0,0,0,0,Oncology,I,Closed,56,Sarah Cannon Research Institut, United States of America (the)
1-ZA6ZB,11/22/2016,1/24/2017,63,0,0,0,0,0,0,CNS,II,Closed,108,Quintiles," Argentina, Brazil, Bulgaria, Canada, Colombia, Czechia, Germany, Japan, Korea (the Republic of), Mexico, Peru, Poland, Russian Federation (the), Spain, United Kingdom of Great Britain and Northern Ireland (the)"
1-ZA72K,10/11/2019,10/11/2019,0,0,0,0,0,0,0,GI,III,Closed,645,Quintiles," Argentina, Australia, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Croatia, Czechia, Denmark, Estonia, Germany, Hungary, Israel, Italy, Japan, Korea (the Republic of), Lithuania, Mexico, Netherlands (the), Poland, Romania, Russian Federation (the), Serbia, Slovakia, South Africa, Spain, Sweden, Taiwan (Province of China), Turkey, Ukraine, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
1-ZA79J,5/17/2020,7/10/2020,54,0,0,0,0,0,0,CNS,II,Cancelled,320,TBD,NULL
1-ZD0U6,4/19/2021,5/17/2021,28,0,0,0,0,0,0,CNS,I,Planned,24,Celerion,NULL
1-ZD806,6/23/2014,8/20/2014,58,0,0,0,0,0,0,CNS,I,Closed,90,Covance, United States of America (the)
1-ZD80F,7/27/2016,9/9/2016,44,0,0,0,0,0,0,CNS,II,Closed,160,Quintiles, United States of America (the)
1-ZD857,1/19/2014,12/10/2014,325,0,0,0,0,0,0,GI,I,Closed,240,Quintiles, United States of America (the)
1-ZF5XK,1/6/2016,3/4/2016,58,0,0,0,0,0,0,CNS,I,Closed,11,PPD, United States of America (the)
1-ZF5ZJ,5/15/2017,8/8/2017,85,0,0,0,0,0,0,CNS,IIIB,Closed,7500,PPD," Canada, Mexico, United States of America (the)"
HGT-MLD-070,2/20/2017,3/13/2017,21,0,0,0,0,0,0,RGH,II,Completed,24,ICON / MAPI / Paradigm," Argentina, Australia, Brazil, Denmark, France, Germany, Japan, Mexico, Poland"
ROPP-2008-01,4/27/2016,6/8/2016,42,0,0,0,0,0,0,RGH,II,Completed,120,PPD," Canada, Italy, Netherlands (the), Poland, Sweden, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the)"
SHP465-308,1/18/2019,2/15/2019,28,0,0,0,0,0,0,CNS,III,Closed,80,PPD, United States of America (the)
SHP465-309,6/8/2018,8/21/2018,74,0,0,0,0,0,0,CNS,III,Completed,60,PPD, United States of America (the)
SHP621-301,2/15/2019,3/15/2019,28,0,0,0,0,0,0,GI,III,Completed,300,PPD," Canada, United States of America (the)"
SHP647-301,7/22/2020,12/4/2020,135,0,0,0,0,0,0,GI,III,Completed,825,TBD," Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, China, Colombia, Croatia, Czechia, Denmark, Egypt, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Jordan, Kenya, Korea (the Republic of), Latvia, Lebanon, Lithuania, Malaysia, Mexico, Moldova (the Republic of), Netherlands (the), New Zealand, Norway, Poland, Portugal, Romania, Russian Federation (the), Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Tunisia, Turkey, Ukraine, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the), Viet Nam"
SHP647-306,8/18/2020,11/25/2020,99,0,0,0,0,0,0,GI,III,Completed,1032,TBD," Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Colombia, Croatia, Czechia, Denmark, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Jordan, Kenya, Korea (the Republic of), Latvia, Lebanon, Lithuania, Malaysia, Mexico, Netherlands (the), New Zealand, Norway, Poland, Portugal, Romania, Russian Federation (the), Serbia, Slovakia, South Africa, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom of Great Britain and Northern Ireland (the), United States of America (the), Viet Nam"
SHP655-101,6/10/2020,8/5/2020,56,1,0,0,0,0,0,RGH,I/II,Execution,56,IQVIA, United States of America (the)
VV_DEN_309,1/3/2020,1/10/2020,7,0,0,0,0,0,0,Vaccine,IIIa,Cancelled,250,PPD,NULL
